|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Physiology, Medical College of Georgia, Augusta, Georgia; 2Department of Pharmacology, University of Sao Paulo, Sao Paulo, SP, Brazil; and 3Kidney Research Centre, University of Ottawa, Ottawa, Ontario, Canada
Submitted 10 March 2008 ; accepted in final form 10 December 2008
Interleukin-10 (IL-10) is an anti-inflammatory cytokine with protective actions on the vasculature. On the other hand, endothelin (ET)-1 has potent vasoconstrictor, mitogenic, and proinflammatory activities, which have been implicated in the pathophysiology of a number of cardiovascular diseases. We hypothesized that, in a condition where ET-1 expression is upregulated, i.e., on infusion of TNF-
, IL-10 confers vascular protection from ET-1-induced injury. Aortic rings and first-order mesenteric arteries from male C57BL/6 (WT) and IL-10-knockout (IL-10–/–) mice were treated with human recombinant TNF-
(220 ng·kg–1·day–1) or vehicle (saline) for 14 days. TNF-
infusion significantly increased blood pressure in IL-10–/–, but not WT, mice. TNF-
augmented vascular ET-1 mRNA expression in arteries from WT and IL-10–/– mice. ET type A (ETA) receptor expression was increased in arteries from IL-10–/– mice, and TNF-
infusion did not change vascular ETA receptor expression in control or IL-10–/– mice. Aorta and mesenteric arteries from TNF-
-infused IL-10–/– mice displayed increased contractile responses to ET-1, but not the ET type B receptor agonist IRL-1620. The ETA receptor antagonist atrasentan completely abolished responses to ET-1 in aorta and mesenteric vessels, whereas the ERK1/2 inhibitor PD-98059 abrogated increased contractions to ET-1 in arteries from TNF-
-infused IL-10–/– mice. Infusion of TNF-
, as well as knockdown of IL-10 (IL-10–/–), induced an increase in total and phosphorylated ERK1/2. These data demonstrate that IL-10 counteracts ETA-mediated vascular responses to ET-1, as well as activation of the ERK1/2 pathway.
tumor necrosis factor-
; vascular reactivity; blood pressure
This article has been cited by other articles:
![]() |
T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1388 - H1397. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |